Literature DB >> 8061279

Biphasic changes in mesolimbic dopamine signal during cocaine self-administration.

E A Kiyatkin1, E A Stein.   

Abstract

High-speed chronoamperometry with Nafion-coated carbon fiber microelectrodes was used to follow changes in extracellular dopamine (DA) concentration in the nucleus accumbens of rats during intravenous cocaine self-administration (SA) behavior. An abrupt, transient decrease in DA-dependent electrochemical signal was found immediately after cocaine SA, whereas the signal slowly increased preceding each lever-press, reaching a peak at the operant response. Procaine, a local anesthetic, also maintained SA behavior in rats previously trained to SA cocaine. Similar to that seen after cocaine, a dose-dependent, abrupt decrease in electrochemical signal was seen following procaine SA, although the pre-pressing signal increase was absent. These data suggest that short-term inhibition of mesolimbic DA release is an immediate consequence of intravenous cocaine SA and may be correlated with the drug's rewarding action. This release inhibition appears to be independent of cocaine's ability to inhibit DA reuptake, a mechanism that would lead to an accumulation of extracellular DA and an increase in electrochemical signal. The coexistence of these two functionally opposite actions of cocaine on mesolimbic DA neurons may be important in mediating cocaine's unique psychogenic and addictive properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061279     DOI: 10.1097/00001756-199404000-00038

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment.

Authors:  J L Neisewander; D A Baker; R A Fuchs; L T Tran-Nguyen; A Palmer; J F Marshall
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats.

Authors:  R A Wise; P Newton; K Leeb; B Burnette; D Pocock; J B Justice
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

Review 3.  Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse.

Authors:  Ingo Willuhn; Matthew J Wanat; Jeremy J Clark; Paul E M Phillips
Journal:  Curr Top Behav Neurosci       Date:  2010

4.  Striatal dopamine release in the rat during a cued lever-press task for food reward and the development of changes over time measured using high-speed voltammetry.

Authors:  Taizo Nakazato
Journal:  Exp Brain Res       Date:  2005-07-19       Impact factor: 1.972

5.  Dual modes of extracellular serotonin changes in the rat ventral striatum modulate adaptation to a social stress environment, studied with wireless voltammetry.

Authors:  Taizo Nakazato
Journal:  Exp Brain Res       Date:  2012-07-12       Impact factor: 1.972

Review 6.  Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

Authors:  Janet L Neisewander; Timothy H C Cheung; Nathan S Pentkowski
Journal:  Neuropharmacology       Date:  2013-08-23       Impact factor: 5.250

7.  Assessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse Potential.

Authors:  A J Brock; S M G Goody; A N Mead; A Sudwarts; M O Parker; C H Brennan
Journal:  J Pharmacol Exp Ther       Date:  2017-08-08       Impact factor: 4.030

Review 8.  Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration.

Authors:  Cody A Siciliano; Erin S Calipari; Mark J Ferris; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2014-12-26       Impact factor: 4.418

9.  Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell.

Authors:  Yuan-Hao Chen; Tung-Tai Kuo; Eagle Yi-Kung Huang; Yu-Ching Chou; Yung-Hsiao Chiang; Barry J Hoffer; Jonathon Miller
Journal:  Oncotarget       Date:  2018-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.